These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4266670)

  • 1. Enhancing antibody: in vitro studies on mechanism of action upon the sensitization and effector arc.
    Phillips SM; Strom TB; Corson JM; Carpenter CB; Merrill JP
    Transplant Proc; 1973 Mar; 5(1):577-80. PubMed ID: 4266670
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of irradiated and mitomycin-treated mouse spleen cells as stimulating cells in mixed lymphocyte cultures and in vitro sensitization.
    Hodes RJ; Terry WD
    J Immunol; 1974 Jul; 113(1):39-44. PubMed ID: 4275549
    [No Abstract]   [Full Text] [Related]  

  • 3. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
    MacDonald HR; Phillips RA; Miller RG
    J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenetic disparity and graft-versus-host reactions.
    Bach ML; Bach FH
    Semin Hematol; 1974 Jul; 11(3):291-303. PubMed ID: 4151845
    [No Abstract]   [Full Text] [Related]  

  • 5. Allograft immunity in vitro. IV. Proliferative response and effector mechanism in mixed cultures of mouse blood lymphocytes.
    Häyry P; Virolainen M; Defendi V
    Transplant Proc; 1971 Mar; 3(1):876-8. PubMed ID: 5095894
    [No Abstract]   [Full Text] [Related]  

  • 6. in vitro quantitation of lymphocyte and serum cytotoxic activity following renal homograft rejection in man.
    Wolf JS; Fawley JC; Hume DM
    Transplant Proc; 1971 Mar; 3(1):449-52. PubMed ID: 4937916
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular immunity in the mouse. 3. In vitro kinetic studies on the relationship between recognition and effector phases.
    Phillips SM; Carpenter CB; Strom TB
    Transplant Proc; 1973 Dec; 5(4):1669-73. PubMed ID: 4130074
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte reactivity in vitro. VI. Specificity of target cell destruction following in vitro sensitization in mixed leukocyte cultures.
    Solliday S; Bach FH
    Eur J Immunol; 1972 Feb; 2(1):68-72. PubMed ID: 4263648
    [No Abstract]   [Full Text] [Related]  

  • 9. Specificity of destruction by lymphocytes activated in mixed leukocyte culture.
    Lightbody JJ; Bach FH
    Transplant Proc; 1972 Sep; 4(3):307-10. PubMed ID: 4263510
    [No Abstract]   [Full Text] [Related]  

  • 10. The application of an in vitro cytotoxicity test to studies of the effects of drugs on the cellular immune response in mice. I. Primary response.
    Fass L; Fefer A
    J Immunol; 1972 Oct; 109(4):749-53. PubMed ID: 5074330
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune responses in vitro. II. Mixed leukocyte interaction in a protein-free medium.
    Katz-Heber E; Peck AB; Click RE
    Eur J Immunol; 1973 Jul; 3(7):379-85. PubMed ID: 4271346
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody-dependent lymphocyte killer function and age.
    McConnachie PR; Rachelefsky G; Stiehm ER; Terasaki PI
    Pediatrics; 1973 Dec; 52(6):795-800. PubMed ID: 4272165
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT; Wagner H; Harris AW
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract]   [Full Text] [Related]  

  • 14. Temperature control of lymphocyte-mediated cytotoxicity in vitro.
    Berke G; Sullivan KA
    Transplant Proc; 1973 Mar; 5(1):421-3. PubMed ID: 4695950
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte activation and destruction in vitro in relation to MLC and HL-A.
    Eijsvoogel VP; Du Bois R; Melief CJ; Zeylemaker WP; Raat-Koning L; de Groot-Kooy L
    Transplant Proc; 1973 Mar; 5(1):415-20. PubMed ID: 4121172
    [No Abstract]   [Full Text] [Related]  

  • 16. The involvement of LD- and SD-region differences in MLC and CML: a three-cell experiment.
    Schendel DJ; Alter BJ; Bach FH
    Transplant Proc; 1973 Dec; 5(4):1651-5. PubMed ID: 4272823
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mercaptoethanol facilitating in vitro the formation of cytotoxic lymphocytes against allogenic cells].
    de Degiovanni G
    C R Seances Soc Biol Fil; 1973; 167(2):391-6. PubMed ID: 4278513
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro reactivity of lymphoid cells from tolerant mice.
    Beverley PC; Brent L; Brooks C; Medawar PB; Simpson E
    Transplant Proc; 1973 Mar; 5(1):679-84. PubMed ID: 4266673
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of an immunoresistant and an immunosusceptible ascites subline from murine tumor TA3. II. Immunosensitivity and antibody-binding capacity in vitro, and immunogenicity in allogeneic mice.
    Friberg S
    J Natl Cancer Inst; 1972 May; 48(5):1477-89. PubMed ID: 4113156
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic control of "in vitro" lymphocyte reactions. New concepts.
    Bach FH
    Biomedicine; 1973 May; 18(3):177-80. PubMed ID: 4270281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.